| Product Code: ETC8893148 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Prophylactic Vaccines Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Prophylactic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Prophylactic Vaccines Market - Industry Life Cycle |
3.4 Portugal Prophylactic Vaccines Market - Porter's Five Forces |
3.5 Portugal Prophylactic Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Portugal Prophylactic Vaccines Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 Portugal Prophylactic Vaccines Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 Portugal Prophylactic Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Portugal Prophylactic Vaccines Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Portugal Prophylactic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing diseases |
4.2.2 Government initiatives to promote vaccination programs |
4.2.3 Rising prevalence of infectious diseases in Portugal |
4.3 Market Restraints |
4.3.1 High cost of prophylactic vaccines |
4.3.2 Vaccine hesitancy among certain population groups |
4.3.3 Regulatory challenges and approval processes for new vaccines |
5 Portugal Prophylactic Vaccines Market Trends |
6 Portugal Prophylactic Vaccines Market, By Types |
6.1 Portugal Prophylactic Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Portugal Prophylactic Vaccines Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Portugal Prophylactic Vaccines Market Revenues & Volume, By Live/Attenuated Vaccines, 2021- 2031F |
6.1.4 Portugal Prophylactic Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F |
6.1.5 Portugal Prophylactic Vaccines Market Revenues & Volume, By Subunit Vaccines, 2021- 2031F |
6.1.6 Portugal Prophylactic Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F |
6.1.7 Portugal Prophylactic Vaccines Market Revenues & Volume, By Conjugate Vaccines, 2021- 2031F |
6.1.8 Portugal Prophylactic Vaccines Market Revenues & Volume, By Recombinant Vector Vaccines, 2021- 2031F |
6.2 Portugal Prophylactic Vaccines Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 Portugal Prophylactic Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F |
6.2.3 Portugal Prophylactic Vaccines Market Revenues & Volume, By Poliovirus, 2021- 2031F |
6.2.4 Portugal Prophylactic Vaccines Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.2.5 Portugal Prophylactic Vaccines Market Revenues & Volume, By Influenza, 2021- 2031F |
6.2.6 Portugal Prophylactic Vaccines Market Revenues & Volume, By Measles, 2021- 2031F |
6.2.7 Portugal Prophylactic Vaccines Market Revenues & Volume, By Mumps, 2021- 2031F |
6.2.8 Portugal Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.2.9 Portugal Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.3 Portugal Prophylactic Vaccines Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 Portugal Prophylactic Vaccines Market Revenues & Volume, By Intramuscular Route, 2021- 2031F |
6.3.3 Portugal Prophylactic Vaccines Market Revenues & Volume, By Subcutaneous Route, 2021- 2031F |
6.3.4 Portugal Prophylactic Vaccines Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3.5 Portugal Prophylactic Vaccines Market Revenues & Volume, By Intravenous Injection, 2021- 2031F |
6.3.6 Portugal Prophylactic Vaccines Market Revenues & Volume, By Administration Routes, 2021- 2031F |
6.4 Portugal Prophylactic Vaccines Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Portugal Prophylactic Vaccines Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Portugal Prophylactic Vaccines Market Revenues & Volume, By Retail Pharmacy and Online Pharmacy, 2021- 2031F |
6.5 Portugal Prophylactic Vaccines Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Portugal Prophylactic Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Portugal Prophylactic Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Portugal Prophylactic Vaccines Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 Portugal Prophylactic Vaccines Market Import-Export Trade Statistics |
7.1 Portugal Prophylactic Vaccines Market Export to Major Countries |
7.2 Portugal Prophylactic Vaccines Market Imports from Major Countries |
8 Portugal Prophylactic Vaccines Market Key Performance Indicators |
8.1 Vaccination coverage rates in target population groups |
8.2 Number of new vaccines introduced into the market |
8.3 Investment in research and development for vaccine innovation |
8.4 Number of public-private partnerships for vaccine distribution and accessibility |
8.5 Rate of adverse events following immunization (AEFI) reporting and management |
9 Portugal Prophylactic Vaccines Market - Opportunity Assessment |
9.1 Portugal Prophylactic Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Portugal Prophylactic Vaccines Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.3 Portugal Prophylactic Vaccines Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 Portugal Prophylactic Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Portugal Prophylactic Vaccines Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Portugal Prophylactic Vaccines Market - Competitive Landscape |
10.1 Portugal Prophylactic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Portugal Prophylactic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here